Jordan Khorshad
Lawyers
Associate in our IP, Tech & Commercial Transactions practice. Previously completed a rotation in Mergers & Acquisitions.
Experience highlights
Recent Representations
- REGENXBIO $140 million stock and pre-funded warrants offering
- Fiserv $2 billion notes offering
- Cisco Systems $13.5 billion notes offering
- NeuroPace $50 million at-the-market offering
- Rollins $1.3 billion inaugural secondary offering
- Fiserv $2 billion notes offering
- NGM Biopharmaceuticals $100 million at-the-market offering
- Noile-Immune Biotech ¥3.1 billion global IPO
- Akoya Biosciences $50 million follow-on offering
- Ionis Pharmaceuticals $575 million convertible senior notes offering
- Fiserv €800 million notes offering
- Alteryx $450 million senior notes offering
- Fiserv $1.8 billion notes offering
- TMS ¥2.9 billion global IPO
- Williams $423 million acquisition of NorTex Midstream Holdings
- Freeman Spogli investment in EverVet
Education
J.D., Brooklyn Law School
- summa cum laude
- Valedictorian
B.A., Vanderbilt University
Professional history
- Davis Polk since 2021
Qualifications and admissions
- State of New York